Skip to content
Screener

Evercore EVR Investment Banking & Equities — Net Revenues

Similar metrics at other companies

ANI Pharmaceuticals logo
ANIPRare Disease total net revenues — Net Revenues
$135.84M+30.7%
ANI Pharmaceuticals logo
ANIPOther generic revenues — Net Revenues
$1.61M-59.0%
Ducommun logo
DCOIndustrial — Net Revenues
$11.32M+50.4%
ANI Pharmaceuticals logo
ANIPBrands — Net Revenues
$11.81M-10.5%
ANI Pharmaceuticals logo
ANIPGenerics and Other total net revenues — Net Revenues
$100.66M+6.8%
Ducommun logo
DCOElectronic Systems — Net Revenues
$131.44M+19.8%

Other financials

Income statement

See full
Revenue$990.2M+18.8%
Net income$95.3M-2.0%
EPS (diluted)$2.32-1.7%

Balance sheet

See full
Cash & equivalents$1.3B+102%
Total debt$1.1B+29.6%
Total equity$1.9B+12.3%
Total assets$4.7B+27.4%

Cash flow

See full
Operating cash flow$525.5M+20.1%
CapEx$10.7M-58.8%
Free cash flow$514.8M+25.0%

Valuation

See full
Market cap$12.33B+6.4%
Enterprise value$12.16B+3.0%
P/E16.6×-8.5×
P/S2.6×-1.0×

Profitability

See full
Net margin15.8%+1.5pp
FCF margin34.5%+11.6pp

Returns & leverage

See full
Return on equity42.4%+13.3pp
Debt / equity0.6×+0.1×
Current ratio2.5×-0.3×

Where this comes from

Reported directly by Evercore in its filing.

Tagged under the XBRL concept us-gaap:RevenuesNetOfInterestExpense.

The source filing: Evercore’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:07 PM EDT
Fiscal quarter
Q4 FY2026
Calendar quarter
Q4 2026
Accession
0001628280-26-053320
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Investment Banking & Equities
Net Revenues(1)$966,877$812,171$2,335,627$1,486,703
Employee Compensation and Benefits627,299535,4471,516,453983,476
Non-Compensation(2)175,789130,773328,445250,547
Special Charges, Including Business Realignment Costs21,31521,315
Operating Income142,474145,951469,414252,680
Income (Loss) from Equity Method Investments181126(27)
Pre-Tax Income$142,492$145,962$469,440$252,653

Item 1. Financial Statements

FAQ

What is Evercore's investment banking & equities — net revenues?
Evercore (EVR) reported investment banking & equities — net revenues of $966.88M in Q2 2026.
How has Evercore's investment banking & equities — net revenues changed year-over-year?
Evercore's investment banking & equities — net revenues increased by 19.0% year-over-year, from $812.17M to $966.88M.
What is the long-term trend for Evercore's investment banking & equities — net revenues?
Over 4 years (2021 to 2025), Evercore's investment banking & equities — net revenues has grown at a 4.0% compound annual growth rate (CAGR), from $3.22B to $3.77B.
What does investment banking & equities — net revenues mean?
The total revenue generated by the segment after deducting interest expense and other direct costs associated with revenue generation. It serves as the primary measure of the segment's top-line contribution to the firm's consolidated financial results. This figure provides a clearer picture of the segment's actual economic output compared to gross revenue.

Ask your AI about Evercore's investment banking & equities — net revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude